BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10638212)

  • 21. Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies.
    Taghizadeh E; Esfehani RJ; Sahebkar A; Parizadeh SM; Rostami D; Mirinezhad M; Poursheikhani A; Mobarhan MG; Pasdar A
    IUBMB Life; 2019 Sep; 71(9):1221-1229. PubMed ID: 31271707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.
    Taghizadeh E; Farahani N; Mardani R; Taheri F; Taghizadeh H; Gheibihayat SM
    Biochem Genet; 2022 Apr; 60(2):453-481. PubMed ID: 34478023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study.
    Coon H; Singh N; Dunn D; Eckfeldt JH; Province MA; Hopkins PN; Weiss R; Hunt SC; Leppert MF;
    Atherosclerosis; 2004 Jun; 174(2):357-62. PubMed ID: 15136067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.
    Pajukanta P; Porkka KV; Antikainen M; Taskinen MR; Perola M; Murtomäki-Repo S; Ehnholm S; Nuotio I; Suurinkeroinen L; Lahdenkari AT; Syvänen AC; Viikari JS; Ehnholm C; Peltonen L
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):841-50. PubMed ID: 9157946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.
    Pajukanta P; Terwilliger JD; Perola M; Hiekkalinna T; Nuotio I; Ellonen P; Parkkonen M; Hartiala J; Ylitalo K; Pihlajamäki J; Porkka K; Laakso M; Viikari J; Ehnholm C; Taskinen MR; Peltonen L
    Am J Hum Genet; 1999 May; 64(5):1453-63. PubMed ID: 10205279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positional cloning of the combined hyperlipidemia gene Hyplip1.
    Bodnar JS; Chatterjee A; Castellani LW; Ross DA; Ohmen J; Cavalcoli J; Wu C; Dains KM; Catanese J; Chu M; Sheth SS; Charugundla K; Demant P; West DB; de Jong P; Lusis AJ
    Nat Genet; 2002 Jan; 30(1):110-6. PubMed ID: 11753387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23.
    Pajukanta P; Nuotio I; Terwilliger JD; Porkka KV; Ylitalo K; Pihlajamäki J; Suomalainen AJ; Syvänen AC; Lehtimäki T; Viikari JS; Laakso M; Taskinen MR; Ehnholm C; Peltonen L
    Nat Genet; 1998 Apr; 18(4):369-73. PubMed ID: 9537421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia.
    Morello F; de Bruin TW; Rotter JI; Pratt RE; van der Kallen CJ; Hladik GA; Dzau VJ; Liew CC; Chen YD
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2149-54. PubMed ID: 15388524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-density lipoprotein particle size loci in familial combined hyperlipidemia: evidence for multiple loci from a genome scan.
    Badzioch MD; Igo RP; Gagnon F; Brunzell JD; Krauss RM; Motulsky AG; Wijsman EM; Jarvik GP
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1942-50. PubMed ID: 15331429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative trait loci for apolipoprotein B, cholesterol, and triglycerides in familial combined hyperlipidemia pedigrees.
    Cantor RM; de Bruin T; Kono N; Napier S; van Nas A; Allayee H; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1935-41. PubMed ID: 15308552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia.
    Tahvanainen E; Pajukanta P; Porkka K; Nieminen S; Ikävalko L; Nuotio I; Taskinen MR; Peltonen L; Ehnholm C
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1810-7. PubMed ID: 9812922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
    Brouwers MC; van Greevenbroek MM; Vermeulen VM; van Lin JM; van der Kallen CJ; de Bruin TW
    Clin Sci (Lond); 2007 Nov; 113(9):375-81. PubMed ID: 17564583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of familial combined hyperlipidemia.
    Pajukanta P; Porkka KV
    Curr Atheroscler Rep; 1999 Jul; 1(1):79-86. PubMed ID: 11122695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.
    Eurlings PM; van der Kallen CJ; Geurts JM; Flavell DM; de Bruin TW
    Mol Genet Metab; 2002 Dec; 77(4):274-81. PubMed ID: 12468272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.
    Geurts JM; Janssen RG; van Greevenbroek MM; van der Kallen CJ; Cantor RM; Bu X; Aouizerat BE; Allayee H; Rotter JI; de Bruin TW
    Hum Mol Genet; 2000 Sep; 9(14):2067-74. PubMed ID: 10958645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia.
    Trinder M; Vikulova D; Pimstone S; Mancini GBJ; Brunham LR
    Atherosclerosis; 2022 Jan; 340():35-43. PubMed ID: 34906840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotype expression in familial combined hyperlipidemia.
    Porkka KV; Nuotio I; Pajukanta P; Ehnholm C; Suurinkeroinen L; Syvänne M; Lehtimäki T; Lahdenkari AT; Lahdenperä S; Ylitalo K; Antikainen M; Perola M; Raitakari OT; Kovanen P; Viikari JS; Peltonen L; Taskinen MR
    Atherosclerosis; 1997 Sep; 133(2):245-53. PubMed ID: 9298685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathway analysis detect potential mechanism for familial combined hyperlipidemia.
    Wang YL; Xue F; Liu LZ; He ZH
    Eur Rev Med Pharmacol Sci; 2013 Jul; 17(14):1909-15. PubMed ID: 23877856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia.
    Vakkilainen J; Pajukanta P; Cantor RM; Nuotio IO; Lahdenperä S; Ylitalo K; Pihlajamäki J; Kovanen PT; Laakso M; Viikari JS; Peltonen L; Taskinen MR
    Eur J Hum Genet; 2002 Sep; 10(9):547-52. PubMed ID: 12173032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age).
    Wiesbauer F; Blessberger H; Azar D; Goliasch G; Wagner O; Gerhold L; Huber K; Widhalm K; Abdolvahab F; Sodeck G; Maurer G; Schillinger M
    Eur Heart J; 2009 May; 30(9):1073-9. PubMed ID: 19276196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.